Theresa M Farrah

Title: The Innovations of Theresa M. Farrah

Introduction

Theresa M. Farrah is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of biotechnology. With a total of six patents to her name, she has made remarkable advancements in the understanding and application of novel receptor polypeptides and soluble proteins.

Latest Patents

One of her latest patents involves the Class II cytokine receptor-7, which includes novel receptor polypeptides, polynucleotides encoding these polypeptides, and related compositions and methods. These polypeptides comprise an extracellular domain of a cell-surface receptor that is expressed in various organs, including the kidneys, pancreas, prostate, adrenal cortex, and nervous tissue. The polypeptides may be utilized in methods for detecting ligands that promote the proliferation and/or differentiation of these organs. Another significant patent is for the soluble protein ZTMPO-1, which relates to polynucleotide and polypeptide molecules for a novel soluble protein with homology to emerin and the thymopoietins. The polypeptides and polynucleotides encoding them are useful for modulating cellular proliferation and differentiation and may also be applied for diagnostic purposes. This invention includes antibodies to the ZTMPO-1 polypeptides.

Career Highlights

Throughout her career, Theresa has worked with notable companies such as Zymogenetics, Inc. and Immunex Corporation. Her work in these organizations has contributed to her expertise and the development of her innovative patents.

Collaborations

Some of her notable coworkers include Si Lok and Anna C. Jelmberg, who have collaborated with her on various projects and research initiatives.

Conclusion

Theresa M. Farrah's contributions to biotechnology through her patents and collaborations highlight her role as an influential inventor in her field. Her work continues to impact the understanding of cellular processes and potential therapeutic applications.